Algo version: 0.98b
RXDX is listed at the NASDAQ Exchange
RXDX [RXDX]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is RXDX stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Prometheus Biosciences 10 years ago, but if you had invested on Friday 12th of March 2021 when the price was $25.29, you would have made a profit of $174.63 per share or 690.51%

Yes, the average daily trading liquidity for Prometheus Biosciences is $164.36 million. You should therefore be able to get in and out of your positions relatively fast.

Prometheus Biosciences has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Prometheus Biosciences to be medium [0.7 out of 1]